Patient‐Reported Outcomes with PD‐1/PD‐L1 Inhibitors for Advanced Cancer: A Meta‐Analysis

BACKGROUND. The aim of this meta‐analysis was to compare patient‐reported outcomes (PROs) between programmed death receptor‐1/programmed death‐ligand 1 (PD‐1/PD‐L1) inhibitors and standard‐of‐care therapy in patients with advanced cancer. METHODS. We searched randomized controlled trials (RCTs) comp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Nishijima, Tomohiro F., Shachar, Shlomit S., Muss, Hyman B., Tamura, Kazuo
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2018
Soggetti:
Symptom Management and Supportive Care
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656437/
https://ncbi.nlm.nih.gov/pubmed/30552160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0449
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi